MED vs ABBV: Dividend Comparison 2026
MED yields 4.00% · ABBV yields 3.67% · See full DRIP projection below
vsEnter any two US tickers
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $11.9K in total portfolio value
10 years
MED
MED
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
ABBV
AbbVie Inc.
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Portfolio growth — MED vs ABBV
Annual dividend income
MED vs ABBV: Complete Analysis 2026
MED — Stock
MED is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in MED shares.
Full MED Calculator →ABBV — Healthcare
AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.
Full ABBV Calculator →Frequently Asked Questions
Is MED or ABBV better for dividend income in 2026?
MED currently offers a 4.00% yield (2.00/share/year) while ABBV offers 3.67% (6.20/share/year). MED provides higher current income. However, ABBV has grown its dividend faster (8.9% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MED vs ABBV earn per year?
With $10,000 invested today: MED pays approximately $400/year. ABBV pays approximately $367/year. With DRIP reinvestment over 10 years, these grow to $899/year (MED) and $1,154/year (ABBV).
Does MED or ABBV pay monthly dividends?
MED pays quarterly dividends. ABBV pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this MED vs ABBV comparison by email
Save your analysis + get weekly dividend insights. Free forever.
More comparisons
⚠️ Educational purposes only. Not financial advice. All projections use historical data; actual results will vary.